Bitcoin price today: surges to $122k, near record high on US regulatory cheer
Meihua International Medical (TASE:BLWV) Technologies Co., Ltd. has announced a transfer of its securities to the Nasdaq Capital Market, effective today. This move follows a notification received by the company on June 3, 2025, from the Nasdaq Stock Market staff, approving the company’s application to list its shares on the Nasdaq Capital Market.
The transfer allows Meihua International an additional 180 days, until December 1, 2025, to comply with the minimum bid price requirement of Nasdaq Listing Rule 5450(a)(1). The company had initially received notice on December 3, 2024, that it was not in compliance with this requirement. To address this, Meihua International applied to transfer from the Nasdaq Global Market to the Nasdaq Capital Market and submitted a compliance plan, which was completed on May 20, 2025.
If Meihua International does not meet the minimum bid price requirement by the end of the extended compliance period, and does not conduct a reverse stock split to raise its stock price above $1.00 for at least 10 consecutive trading days, its ordinary shares will face delisting. The company states it will continue to monitor the situation and take necessary actions to meet all Nasdaq continued listing requirements.
This information is based on a press release statement filed with the U.S. Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.